STONY BROOK, N.Y. – March 22, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted a validation package to the New York State Department of Health (NYSDOH) in support of [...]
TÜV SÜD America Inc., a global leader in testing, inspection / audit and certification, announces a new collaboration with Applied DNA Sciences (ADNAS) to offer their scientific traceability services as a complement to TÜV SÜD’s product traceability solution. Applied DNA’s molecular DNA-based supply chain security and [...]
STONY BROOK, N.Y. – February 9, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for the first quarter of fiscal 2023, ended December 31, 2022. “Applied DNA delivered a solid start to [...]
STONY BROOK, N.Y. – February 2, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a [...]
STONY BROOK, N.Y. – January 5, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced the publication of a peer-reviewed research article in Molecular Therapy – Methods & Clinical Development. The study, titled ‘A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits [...]
STONY BROOK, N.Y. - December 14, 2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for the fourth quarter and fiscal year ended September 30, 2022. “Applied DNA delivered four consecutive quarters of year-over-year revenue increases [...]
STONY BROOK, N.Y. - December 12, 2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that it plans to release its fiscal 2022 fourth quarter and year-end financial results after the market close on Wednesday, December 14, 2022. The Company’s management will host a conference [...]
Almost exactly a year ago, the Congress with a unanimous vote passed the Uyghur Forced Labor Prevention Act (UFLPA). No partisan divide exists with the American people: they want forced labor out of their imported products, and are especially concerned by the human rights violations against the Muslim minorities of the Xinjiang Uyghur Autonomous Region of China, [...]
STONY BROOK, N.Y. – October 24, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced today plans to establish a new, separate manufacturing facility to be located in Suffolk County, New York, for the enzymatic production of cGMP LinearDNA™ for use [...]